Cancer proteomics: from biomarker discovery to signal pathway profiling.
In the post-genomic era of science, the field of proteomics promises the discovery of new molecular targets for therapy, biomarkers for early detection, and new endpoints for therapeutic efficacy and toxicity. Patient-specific targeted therapeutics with reduced toxicity and increased efficacy, the u...
| Published in: | Cancer Journal Vol. 7; no. 1; pp. 69 - 70 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Published: |
Lippincott Williams & Wilkins
Jan/Feb2001
|
| Online Access: | View this record in EBSCOhost |